Conference Calls and Earnings Call Transcripts for NSE and BSE Stocks

Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans for NSE and BSE Stocks

announcement
Conference/Earnings Calls Alerts
173.27
-2.57%
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform the stock exchanges that the Company has uploaded the audio recording of investor(s) / analyst(s) meet for Q4FY25 financial performance and strategy update held today i.e. May 20, 2025 on the Company's website at http://marksanspharma.com/investors-meet.html
2159.80
-1.25%
1927.50
-0.70%
Conference Call with Gland Pharma Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
16668.00
-2.06%

Conference Call with Dixon Technologies (India) Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

3604.80
-1.90%
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
3604.80
-1.90%
1575.50
-2.17%
3425.40
0.09%
987.85
-3.45%
173.27
-2.57%
Conference Call with Marksans Pharma Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

Earnings Calls Podcast on